Small-Molecule Respiratory Drug Market to Reach USD 61.41 Billion by 2034 at 7.0% CAGR as Asthma, COPD Management and Advanced Respiratory Therapies Accelerate Demand According to a report by IntelMarketResearch, the Global Small-Molecule Respiratory Drug Market was valued at USD 38.493 billion in 2025 and is projected to reach USD 61.413 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 7.0% during 2026–2034. The global small-molecule respiratory drug market is experiencing steady expansion as healthcare systems increasingly focus on the long-term management of chronic respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). Growing demand for effective maintenance therapies, improvements in inhalation drug delivery and the development of differentiated pharmaceutical formulations are creating significant opportunities for respiratory drug manufacturers View the full Small-Molecule Respiratory Drug Market forecast and competitive analysis: https://www.intelmarketresearch.com/small-molecule-respiratory-drug-market-53-64771 Get a preview with Free Report copy: https://www.intelmarketresearch.com/download-free-sample/64771/small-molecule-respiratory-drug-market-53 Contact: IntelMarketResearch Phone: +91 9169164321 Email: help@intelmarketresearch.com Website: https://www.intelmarketresearch.com